SEC Company Response from Propanc Biopharma, Inc. (PPCB) (CIK 0001517681) (PPCB) — Oct 26, 2018
Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)
Date: Oct. 26, 2018 · CIK: 0001517681 · Accession: 0001493152-18-014875
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227877
Letter
PROPANC BIOPHARMA, INC.
302, 6 Butler Street
Camberwell, VIC, 3124 Australia
October 26, 2018
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
F Street N.E.
Washington, D.C. 20549
Re: Propanc Biopharma, Inc.
Registration Statement on Form S-1
File No. 333-227877
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be accelerated so that it will become effective at 10:00 A.M. Eastern Time on Tuesday, October 30, 2018, or as soon as practicable thereafter.
We request that we be notified of such effectiveness by a telephone call to Jonathan Shechter of Foley Shechter LLP at (212) 335-0465, or in his absence Sasha Ablovatskiy of Foley Shechter LLP at (212) 335-0466. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of such Registration Statement be sent to Foley Shechter LLP, attention: Jonathan Shechter, via facsimile at (917) 688-4092.
Sincerely,
PROPANC
BIOPHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
PROPANC
BIOPHARMA, INC.
302,
6 Butler Street
Camberwell,
VIC, 3124 Australia
October
26, 2018
VIA
EDGAR
Division
of Corporation Finance
U.S.
Securities and Exchange Commission
100
F Street N.E.
Washington,
D.C. 20549
Re:
Propanc
Biopharma, Inc.
Registration
Statement on Form S-1
File
No. 333-227877
Ladies
and Gentleman:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. (the “Company”) hereby requests
that the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”)
be accelerated so that it will become effective at 10:00 A.M. Eastern Time on Tuesday, October 30, 2018, or as soon
as practicable thereafter.
We
request that we be notified of such effectiveness by a telephone call to Jonathan Shechter of Foley Shechter LLP at (212) 335-0465,
or in his absence Sasha Ablovatskiy of Foley Shechter LLP at (212) 335-0466. We also respectfully request that a copy of
the written order from the Securities and Exchange Commission verifying the effective time and date of such Registration Statement
be sent to Foley Shechter LLP, attention: Jonathan Shechter, via facsimile at (917) 688-4092.
Sincerely,
PROPANC
BIOPHARMA, INC.
By:
/s/
James Nathanielsz
Name:
James
Nathanielsz
Title:
Chief
Executive Officer and Chief Financial Officer
Cc:
Jonathan
Shechter, Foley Shechter LLP
Sasha
Ablovatskiy, Foley Shechter LLP